(Q33241517)

24 July 2017

title

Eradication of common pathogens at days 2, 3 and 4 of moxifloxacin therapy in patients with acute bacterial sinusitis (English)

1 reference

eradication of infectious diseases

24 July 2017

main subject

1 reference

1 reference

Horacio Ariza

1

1 reference

24 July 2017

Ramon Rojas

2

1 reference

24 July 2017

Peter Johnson

3

1 reference

24 July 2017

Richard Gower

4

1 reference

24 July 2017

Alice Benson

5

1 reference

24 July 2017

Janet Herrington

6

1 reference

24 July 2017

Renee Perroncel

7

1 reference

24 July 2017

Peter Pertel

8

1 reference

24 July 2017

publication date

28 April 2006

1 reference

BMC Ear, Nose and Throat Disorders

24 July 2017

published in

1 reference

24 July 2017

volume

6

1 reference

24 July 2017

page(s)

8

1 reference

Efficacy and tolerability of moxifloxacin in patients with sinusitis treated in general practice : results of a post-marketing surveillance study

24 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1508156

New fluoroquinolones in lower respiratory tract infections and emerging patterns of pneumococcal resistance

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1508156

Antimicrobial treatment guidelines for acute bacterial rhinosinusitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1508156

Benchmarking the in vitro activities of moxifloxacin and comparator agents against recent respiratory isolates from 377 medical centers throughout the United States

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1508156

Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997 98.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1508156

Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: a prospective U.S. study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1508156

Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. Surveillance study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1508156

The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6815-6-8

Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6815-6-8

A prospective, multicentre study of moxifloxacin concentrations in the sinus mucosa tissue of patients undergoing elective surgery of the sinus

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6815-6-8

Moxifloxacin in the Treatment of Acute Maxillary Sinusitis after First-Line Treatment Failure and Acute Sinusitis with High Risk of Complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6815-6-8

Comparison of the efficacy and safety of moxifloxacin and trovafloxacin for the treatment of acute, bacterial maxillary sinusitis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6815-6-8

Efficacy and tolerability of once-daily therapy with telithromycin for 5 or 10 days for the treatment of acute maxillary sinusitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6815-6-8

Short treatment durations for acute bacterial rhinosinusitis: Five days of gemifloxacin versus 7 days of gemifloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6815-6-8

Endoscopically directed middle meatal cultures versus maxillary sinus taps in acute bacterial maxillary rhinosinusitis: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6815-6-8

Use of pharmacodynamic end points in the evaluation of gatifloxacin for the treatment of acute maxillary sinusitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6815-6-8

A comparison of the safety and efficacy of moxifloxacin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults. The Sinusitis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6815-6-8

Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis. Sinusitis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6815-6-8

Rigid nasal endoscopy versus sinus puncture and aspiration for microbiologic documentation of acute bacterial maxillary sinusitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6815-6-8

Comparative in vitro activity of gatifloxacin, grepafloxacin, levofloxacin, moxifloxacin and trovafloxacin against 4151 Gram-negative and Gram-positive organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6815-6-8

Randomized controlled trial of 3 vs 10 days of trimethoprim/sulfamethoxazole for acute maxillary sinusitis

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16646958

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1472-6815-6-8

1 reference

Dimensions Publication ID

24 July 2017

0 references

1 reference

24 July 2017

1 reference